HONG KONG – China's biotechnology industry and ecosystem is growing and approaching a critical mass in terms of innovation, financing and talent. That was the message May 29 during the second biotech summit held by the Hong Kong Stock Exchange (HKEX).

HONG KONG – Many agree that a biotech ecosystem is growing and approaching critical mass in China. But for the industry to leap, biotech scientists point to the need for more clinical talent and a better reimbursement system, while health care investors want to see the ecosystem maturing. 

HONG KONG – Many agree that a biotech ecosystem is growing and approaching critical mass in China. But for the industry to leap, biotech scientists point to the need for more clinical talent and a better reimbursement system, while health care investors want to see the ecosystem maturing. 

HONG KONG – China's biotechnology industry and ecosystem is growing and approaching a critical mass in terms of innovation, financing and talent. That was the message Wednesday during the second biotech summit held by the Hong Kong Stock Exchange (HKEX).

HONG KONG – China has again demonstrated efforts to improve its health care system by motivating drug innovation and strengthening regulation. This time it is being done through overhauling the country's drug administration law and introducing a similar law for vaccines.

HONG KONG – China has again demonstrated efforts to improve its health care system by motivating drug innovation and strengthening regulation. This time it is being done through overhauling the country's drug administration law and introducing a similar law for vaccines.